Advertisement
Proactive bone-health management may reduce morbidity and mortality
Falling from standing height should not break bones
Advancing our knowledge of risk factors
Center for Geriatric Medicine leads inpatient care of fragility fractures
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Results of the largest population-based study to date
Benefit/AFF risk ratio favors 3–5 years of treatment
If denosumab is stopped, it should be replaced with another osteoporosis treatment
Romosozumab builds more bone than any previous medication
Dual-acting drug increases bone formation while decreasing resorption
What the updated evidence-based guidelines mean for your patients
Advertisement
Advertisement